
--- Page 1 ---
PsH- Sih: Breast, lppw outwqusdrert c50.4 CQcF- Braot, Nos C50.9 1201 Procedure Date: Procedure Physician: ase is [circle Attending Physician/Copies To: .UALISIED CISCUALIFIED UUID:E2EE2397-0F8A-4A71-983C-0007F7D00500 PatIent hIstory: TCGA-BH-A1F0-01A-PR Redacted + DaTe of LMp: * DATE OF LAST DELIVERY: PRE-OP DIAGNOSIS: L BREAST CA POST-OP DIAGNOSIS: SAME OPERATIVE PROCEDURR: LEFT TOTAL MASTECTOMY, LEFT AXILLARY SAMPLING CLINICAL HISTORY: * MATERIAL SUEAITTAD: LEFT (MOD) RADICAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE INTRAOPERATIVE CONSULTATION: Left breast with axillary sampling. Mass identified at 1:00 position, 2.0 by 2.0 by 2.0 cm. Second lesion, just lateral to first, 1.s by 1.5 by l.0 cm. Surgical margins grossly free for both tumors. Axillary tail containing fatty lymph node with blue coloration (treat as sentinel node). REVISEDRERORT -IAGNOSIS: - **OUTER** QUADRANT **MULTIFOCAL** IN UPPER - SIZk-OF THE FOCI ARE 2.0 BY 2.0 BY 2.0 **AND++ 1.5 aY 1.5 BY 1.0 CX **DOTH** TUMORS HAVE IDENTICAL MORPHOLOGY - NOTTINGHAM SCORE-8 (TUBULES-3, NUCLEAR ATYPIA-3, MITOSIS-2) ALL SURGICAL MARGINS FREE OF TUMOR - NIRPLE AND AREOLA WITH NO DIAGNOSTIC CHANGES NON-NEOPLASTIC BRZAST WITH NO DIAGNOSTIC CHANGRS ONE (1) LYMPH NODE (SENTINEL); POSITIVE FOR METASTATIC CARCINCMA (1/9) NOTe: The micrometastasis msasures 1.5 mm and was identiried both on Hce and immunoparoxidase stain. AJCC stage Tic Nla Mx. ++The two tumor nodulos are located in upper outer quadrant. The tumor adjacent to the nipple mantioned in the previous report, is part of one of the two tumor nodules.*+ er/pr immunoperoxidas. assay and Her-2/nxu testing will be performed on block "A2". ** REVISION (GROSS DESCRIPTION) Addendum MATERIAL SUBMITTED: BLOCK "A2" AND "A4" FOR ER/PR AND HER-2/NEU FINAL DIAGNOSIS: ER/PR RESULTS ("A2") IMMUNOPEROXIDASE IDENTIFICATION OF ESTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE "A2". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIKD FOCALLY FOR PROGESTERONE RECEPTOR (1St) BUT NOT FOR ESTROGEN RECEPTOR. THERETORE, PROGESTERONE RECEPTOR IS INTERPRETED AS BORDERLINE AND ESTROGEN RECEPTOR AS NEGATIYE. HER-2/NEU RESULTS ("A2") AS PER THE REQUEST OF DR. . C-erbB2 (HER-2/NEU) IMUNOSTAINING IS CARRI5D OUT ON PREVIOUS MAGRE SURGICAL S (BREAST CANCER) USING A 1:3OO DILUTICN OF DAKO'S POLXCLONAL ANTIBODY AAQ5 (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF C-OrbB2) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COMPLETES BR/PR RESULTSS"AS") IMMUNOPEROXIDASE IDENTIFICATION Or BSTROGEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE "A4". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOCALLY FOR PROCESTGERONE RECEPTOR (1St) BUT NOT FOR BSTROGEN RECEPTOR. THERETORE, PROGKSTERONE RECEPTOR IS INTERPRETED AS BORDERLINE AND ESTROCEN RECEPTOR AS NEGATIVE. HER-2/NSU RESULTS A4" AS PER THE REQUEST OF DR. . C-erbB2 (HER-2/NEU) IMANOSTAINING I8 CARRIED OUT ON PREVICUS MAGEB SM (AREAST CANCER) USING A 1:3OO DILUTION OF DAKO'S POLYCLONAL ANTIBODY A485 (DIRECTED AGAINST THE^INTRACELLULAR DOMAIN OF c-erbB2) WITHOUT ANTIGEN RETRIEVAL. NO DISTINCT COCPLETE MEMBRANE STAINING IS IDENTIFIED. THEREFORS, C-erbB2 (HER-2/NEU) IS INTERPRETSD AS NEGATIVE. (SCORE 0).